Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 3/25/14 → 3/25/17 |
Funding
- INC Research, LLC (Prot #CE01-301 // Prot #CE01-301)
- Cempra Pharmaceuticals, Inc. (Prot #CE01-301 // Prot #CE01-301)
Prot #CE01-301: A Randomized, Double-Blind, Multi-Center Study to Evaluate the Efficacy and Safety of Intravenous to Oral Solithromycin (CEM-101) Compared to Intravenous to Oral Moxifloxacin in the Treatment of Adult Patients with Community-Acquired Bacte
- Wunderink, Richard G (PD/PI)
Project: Research project